Overview of the regulatory approval of tecovirimat intravenous formulation for treatment of smallpox: potential impact on smallpox outbreak response capabilities, and future tecovirimat development potential.
Saved in:
| Title: | Overview of the regulatory approval of tecovirimat intravenous formulation for treatment of smallpox: potential impact on smallpox outbreak response capabilities, and future tecovirimat development potential. |
|---|---|
| Authors: | Russo AT; SIGA Technologies, Inc, Corvallis, OR, USA., Grosenbach DW; SIGA Technologies, Inc, Corvallis, OR, USA., Honeychurch KM; SIGA Technologies, Inc, Corvallis, OR, USA., Long PG; SIGA Technologies, Inc, Corvallis, OR, USA., Hruby DE; SIGA Technologies, Inc, Corvallis, OR, USA. |
| Source: | Expert review of anti-infective therapy [Expert Rev Anti Infect Ther] 2023 Mar; Vol. 21 (3), pp. 235-242. Date of Electronic Publication: 2023 Feb 02. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 101181284 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8336 (Electronic) Linking ISSN: 14787210 NLM ISO Abbreviation: Expert Rev Anti Infect Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
